STSS Sharps Tech Total Debt to Capital

STSS (Sharps Technology Inc) - company brandmark

This chart of the total debt-to-equity ratio for Sharps Technology, Inc. (STSS) currently stands at 0.00. Sharps Technology, Inc. (STSS) develops innovative reuse-blocking syringes for the hospital sector and non-profit organizations. High barriers to entry are ensured by patents for protective mechanisms and strict sterilization standards, while the brand implements polymer solutions that reduce plastic waste in medicine.

Debt to Equity Ratio: Sharps Technology Inc (STSS) for 04/28/2023 - 05/28/2026
Brand item of Sharps Technology

Significant capital expenditures are required for the expansion of Sharps Technology, Inc. (STSS) within the safe drug delivery systems segment. This ratio of financial obligations to equity reflects the balance between the company's borrowed resources and its own funds. The metric is calculated by dividing total debt by the amount of shareholder equity. High values signal a risk of default, while low values indicate conservative management. It is critical for investors to evaluate this leverage to understand the financial stability of the business.

Analysis of competing companies

Debt to Equity ISRG|Total Debt to Equity Ratio Danaher Corporation|Becton, Dickinson and Company - Total Debt to Capital|Debt to Capital STERIS Group (STE)|WST - Total Debt to Capital|Debt to Equity Ratio baxter.com BAX|Total Debt to Capital MASI (Masimo)|STVN - Total Debt to Capital Coefficient|TFX (Teleflex Inc) - Total Debt to Capital|Merit Medical Corp (MMSI) - Total Debt to Equity Ratio|NVST (Envista Holdings) - Total Debt to Capital|Total Debt to Capital ICUI|Debt to Equity Dentsply Sirona (XRAY)|Debt to Equity LeMaitre Vascular Inc LMAT|Total Debt to Equity Ratio AtriCure Corp|All Debt to Shareholders' Equity Ratio STAAR Surgical Co STAA|Total Debt to Capital NAGE (ChromaDex Corp.)|ZIMV: Total Debt to Capital Coefficient|Debt to Equity AngioDynamics|CERS (Cerus Corp.) - Debt to Equity Ratio|TKNO: Debt to Equity|Total Debt to Capital Coefficient Monogram Orthopedics Inc. (MGRM)|Total Debt to Equity Ratio InfuSystem Holdings|Aggregate Debt to Capital UTMD (utahmed.com)|Debt to Equity KORU Medical|NYXH - All Debt to Shareholders' Equity Ratio|Microbot Medical Inc - Total Debt to Equity Ratio|PDEX: Total Debt to Capital|ZTEK (Zentek Ltd.) - Debt to Equity|elutia.com (ELUT) - Total Debt to Equity Ratio|Total Debt to Capital MLSS (Milestone Scientific Inc.)|Debt to Capital NXGL|Debt to Equity Retractable Technologies RVP|Debt to Equity Ratio harvardbioscience.com HBIO|Total Debt to Equity Ratio Femasys Inc. (FEMY)|Meihua Medical Technologies - Aggregate Debt to Capital|Debt to Equity POAI (Predictive Oncology Corp)|CJMB: Total Debt to Capital Coefficient|Atrion Corp - Debt to Equity|NeuroMetrix Corporation (NURO) - Total Debt to Capital Coefficient